Cardiac Risks of Diabetes Drugs a Focus at EASD

EASD 2013 — BARCELONA — A major focus of the upcoming meeting of the European Association for the Study of Diabetes here will be the risks and benefits of the incretin-based therapies, according to the chair of the program committee.

< Back to Listings